Lithuania: Biobanks – Is Lithuania Ready For Them?

Last Updated: 3 October 2012
Article by Edvinas Meskys

Currently a large part of politicians, economists and lawyers are working hard to ensure that a recent bank bankruptcy story would not repeat itself. Quite often people associate the term "bank" with instability, possibility to lose something or lack of transparent governing. Maybe this is the reason why there are no biobanks in Lithuanian which are wide-spread in the EU and other countries of the world. But maybe the lack of knowledge causes such situation because people often are afraid of things they don't know.

What is a biobank?

There are various definitions of biobanks. One version says that biobank is a well-organized system which stores and manages human biological samples and medical documents for the sole purpose - to achieve scientific research goals. Shortly speaking, a biobank is a place with special tanks where samples of human organs, their parts, tissues, cells or their components, taken from the human body, are stored. All these components have a general name – biological material.

Some people may find the idea of biobanks strange but only this kind of storing and managing system would allow Lithuania to develop new research of cancer, genetic and other diseases, therefore it would serve the interest of the whole society and of each Lithuanian citizen. The purpose of a biobank is to accumulate material for future research after new technologies will be developed or new ways of research will be found, new symptoms of diseases will be discovered, etc. Things that were unclear 20 years ago are easily explainable at present, so we can only guess what kind of possibilities we will have after several decades.

Applicable laws contradict the essence of biobanks' functioning

Under the applicable laws all biomedical researches are conducted only with a written consent of the subject of the research. Before giving the consent, the subject is informed in a form which is comprehendible for him/her and is signed by him/her, about the aim, plan and methods of a particular biomedical research and receives other important information. Biological materials are stored in biobanks and researches in most cases are not planned in advance, therefore there is no possibility to inform the subject who donates the biological material for scientific purposes about the precise details of the research. It is similar to blood donation – a donor does not ask a doctor to which patient his or her blood will be transfused.

Special consent of a person is necessary

A biobank needs a specific-general permit which allows the researcher to conduct a research at any time and as many times as needed in accordance with strict requirements of legal acts and with a consent of the supervising institution. The control of biological material may be ensured by including a provision to the law which would give a possibility for a person to get general information on whether his/her biological material was used for the biomedical research during the last year. Hardly a person who allowed to store in a biobank the sample of the malignant tumour removed during an operation would wish to receive constant calls from the researchers with a request of consent to use the sample. In such cases people wish to forget about the past and the disease and feel happy at the same time that his/her donated medical material could help to find cures or method of treatment of the same disease.

There are numerous ways how biobanks in all over the world carry consents of donors. Some are very liberal "presumed" consents, which allow storing biological material without a consent of a person when it cannot be received because of objective reasons, and later on allow to cancel this consent. Other consents allow to conduct only particular (marked in the consent) actions, e.g. for cancer research.

Lithuania is one out of few countries which do not have biobanks

Despite the evident benefit of biobanks to society, science and even economy (biobanks in foreign countries often encourage international pharmaceutical companies and researchers to establish laboratories for scientific researches which employ local scientists, also patent invented medicaments in those countries and collect taxes, etc.), Lithuanian lags behind, practically and in terms of regulations, the other EU Member States where biobanks operate for a long time. The advantages of biobanks are appreciated not only in the US or Western European countries but also in our neighbouring countries – Latvia and Estonia, which is particularly innovative in this area. Whereas Lithuania languidly solves this problem and therefore science in our country cannot use the potential in the field of biomedicine. Because of that patients cannot approach the most innovative methods of diagnostics and treatment and the objective to attract investments from the largest pharmaceutical companies remains declarative.

Amendment of the law is prepared

This situation could be changed by the working group of the Committee of Health Affairs of the Seimas, which prepares the draft of amendment to the Law on Ethics of Biomedical Research of the Republic of Lithuania in which it is sought to legitimise the activities of biobanks in Lithuania. The draft of the amendment defines rights and duties of biobanks, regulates the issues of collection, storage and handover of human biological samples to researchers, sets a strict protection of interests of a person who's biological material is being processed, includes a special protection for vulnerable persons, solves the problem of coding information about a person so that researchers could not get access to it and determines what part of information should be given to society or a concerned member of it.

Unfortunately, there are obstacles to this draft. Even though Lithuania declares innovative goals, it's not the first time when legal regulations encounter luddites, ultra-conservative provisions and bureaucracy. Legislators are afraid of various risks, hidden interests and worst scenarios (trafficking in human organs, etc.) and because of that it is offered to impose numerous pointless hurdles and bureaucratic control mechanisms on biobanks. Sadly, nobody realises that such regulations may impede the development of biomedical research in general and many doctors and young scholars could be lost because of that.

Development of biobanks in the EU once again discussed in the EU Council

Not only Lithuanian lawyers but also European institutions stress the need for clarity and flexibility in the area of biomedicine. In June a symposium of scholars, lawyers, legislators and representatives from public organisations from all over the world took place in the Council of Europe, Strasbourg. The participants of it were discussing the need to renew the 2006 Recommendation on research on biological materials of human origin. This symposium once again stressed the benefit of biobanks in the entire EU, discussed the possibilities of common biobanks' system, information exchange methods and possible problems.

It is obvious that Lithuania is in the initial status of creation of biobanks and has no possibilities to talk about joining the common EU information system which would be accessed by EU researchers. But observing achievements in other countries we have a chance to use their good practice and stop trying solving problems which have been already solved. For example, one of the biggest issues in Lithuania is the security of person's privacy. There are fears that humans' biological material (samples) could be related to other information such as medical history, personal number, etc. During the symposium attention has been paid to the issue that absolute anonymity does not exist, because a person could be identified after analysis and comparison of biological materials with the DNA of the person. Considering this, we should think hard whether the benefit that we get (e.g. new medicine and ways of treatment) does not counterbalance the possible theoretical risk of the disclosure of personal data. Very often people themselves publish their personal data, for example in the Facebook, so we should ask ourselves what would happen if some scholar would find out my identity.

From lawyers' point of view, nobody denies that personal privacy should be protected as much as it is possible, for example by coding the information transmitted to the scientist. But privacy should not be underestimated by giving up on other possibilities; there are two sides of a coin. Every person makes its own decision whether he/she wants to give samples to the biobank and evaluates every possible consequence. This opinion has been confirmed by one speaker of the symposium which represents an association of people ill with very rare diseases. She said that the majority of the members of the association would accept to give their biological material to a biobank without any confidentiality, i.e. without coding the information, only if it could increase the possibility for scientists to find the cure to their disease and save lives.

The future of Lithuania in the area of biomedical researches depends only on us

It would be very hard to find arguments why Lithuania should remain one of those few countries in the EU and all over the world which do not create new possibilities for science and do not establish biobanks.

Difficult questions had risen in other countries as well, but they had been solved or at least they are being solved. It does not mean that other countries do not respect personal privacy or are not afraid of other problems, but there is a big gap between us and other countries. For example, Malmö Microbiology biobank in Sweden collects samples since 1969, whereas we still discuss whether biobanks are needed at all. The vast majority of society have never heard about biobanks and don't know the benefits it may offer. Maybe in near future it will change because now at least we have discussions on this issue.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Related Topics
 
Related Articles
 
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions